Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model

Annals of Otology, Rhinology and Laryngology

Volumn 116, Issue 10, 2007, Pages 762-769

  Ohno, Tsunehisa ^a   Hirano, Shigeru ^a   Kanemaru, Shin Ichi ^a   Yamashita, Masaru ^a   Umeda, Hiroo ^a   Suehiro, Atsushi ^a   Tamura, Yoshihiro ^a   Nakamura, Tatsuo ^b   Ito, Juichi ^a   Tabata, Yasuhiko ^b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Drug delivery system; Gelatin hydrogel; Hepatocyte growth factor; Vocal fold scarring

Indexed keywords

COLLAGEN; RECOMBINANT SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG DELIVERY SYSTEM; HISTOLOGY; HYDROGEL; LARYNX; NONHUMAN; PRIORITY JOURNAL; SCAR FORMATION; TREATMENT OUTCOME; VIBRATION; VOCAL CORD;

EID: 35348889097     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940711601008     Document Type: Article

References (24)

1. Ford CN, Bless DM. Collagen injection in the scarred vocal fold. J Voice 1987;1:116-8.
2. Staskowski PA, Ford CN, Inagi K. The histologic fate of autologous collagen injected into the canine vocal fold. Otolaryngol Head Neck Surg 1998;118:187-90.
3. Kriesel KJ, Thibeault SL, Chan RW, et al. Treatment of vocal fold scarring: rheological and histological measures of homologous collagen matrix. Ann Otol Rhinol Laryngol 2002; 111:884-9.
4. Brandenburg JH, Kirkham W, Koschkee D. Vocal cord augmentation with autogenous fat. Laryngoscope 1992;102:495-500.
5. Thibeault SL, Gray SD, Bless DM, Chan RW, Ford CN. Histologic and rheologic characterization of vocal fold scarring. J Voice 2002;16:96-104.
6. Gray SD, Titze IR, Chan R, Hammond TH. Vocal fold proteoglycans and their influence on biomechanics. Laryngoscope 1999;109:845-54.
7. Savani R, Bagli DJ, Harrison RE, Turley EA. The role of hyaluronan-receptor interactions in wound repair. In: Garg HG, Longaker MT, eds. Scarless wound healing. New York, NY: Marcel Dekker, 2000:115-37.
8. Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997;239:639-44.
9. Hirano S, Bless DM, Heisey D, Ford C. Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts. Laryngoscope 2003;113:144-8.
10. Hirano S, Bless DM, Rousseau B, et al. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope 2004;114:548-56.
11. Hirano S, Bless DM, Nagai H, et al. Growth factor therapy for vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol 2004;113:777-85.
12. Ozeki M, Ishii T, Hirano Y, Tabata Y. Controlled release of hepatocyte growth factor from gelatin hydrogels based on hydrogel degradation. J Drug Target 2001;9:461-71.
13. Ikada Y, Tabata Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 1998;31:287-301.
14. Sakaguchi G, Tambara K, Sakakibara Y, et al. Control-released hepatocyte growth factor prevents the progression of heart failure in stroke-prone spontaneously hypertensive rats. Ann Thorac Surg 2005;79:1627-34.
15. Haraguchi T, Okada K, Tabata Y, Maniwa Y, Hayashi Y, Okita Y. Controlled release of basic fibroblast growth factor from gelatin hydrogel sheet improves structural and physiological properties of vein graft in rat. Arterioscler Thromb Vasc Biol 2007;27:548-55.
16. Nakae M, Kamiya H, Naruse K, et al. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes 2006;55:1470-7.
17. Hokugo A, Sawada Y, Hokugo R, et al. Controlled release of platelet growth factors enhances bone regeneration at rabbit calvaria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:44-8.
18. Hori K, Sotozono C, Hamuro J, et al. Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing. J Control Release 2007;118:169-76.
19. Hirano M. Phonosurgery: past, present, and future. Trans Am Broncho-Esophagol Assoc 1995:25-30.
20. Rousseau B, Hirano S, Chan RW, et al. Characterization of chronic vocal fold scarring in a rabbit model. J Voice 2004; 18:116-24.
21. Rousseau B, Hirano S, Scheidt TD, et al. Characterization of vocal fold scarring in a canine model. Laryngoscope 2003;113:620-7.
22. Hirano S, Bless DM, Rousseau B, Welham N, Scheidt T, Ford CN. Fibronectin and adhesion molecules on canine scarred vocal folds. Laryngoscope 2003;113:966-72.
23. Kanemaru S, Nakamura T, Omori K, et al. Regeneration of the vocal fold using autologous mesenchymal stem cells. Ann Otol Rhinol Laryngol 2003;112:915-20.
24. Kanemaru S, Nakamura T, Yamashita M, et al. Destiny of autologous bone marrow-derived stromal cells implanted in the vocal fold. Ann Otol Rhinol Laryngol 2005;114:907-12.